Wan Z, Chen Y, Hui J, Guo Y, Peng X, Wang M
Virol J. 2023; 20(1):107.
PMID: 37259131
PMC: 10230783.
DOI: 10.1186/s12985-023-02078-z.
Ahmed N, Abusalah M, Farzand A, Absar M, Yusof N, Rabaan A
Medicina (Kaunas). 2023; 59(1).
PMID: 36676626
PMC: 9863520.
DOI: 10.3390/medicina59010002.
Singh S, Homad L, Akins N, Stoffers C, Lackhar S, Malhi H
Cell Rep Med. 2020; 1(3).
PMID: 32724901
PMC: 7386402.
DOI: 10.1016/j.xcrm.2020.100033.
Imai A, Takase H, Imadome K, Matsuda G, Ohnishi I, Yamamoto K
Intern Med. 2017; 56(11):1409-1414.
PMID: 28566607
PMC: 5498208.
DOI: 10.2169/internalmedicine.56.7573.
Gantuz M, Lorenzetti M, Chabay P, Preciado M
PLoS One. 2017; 12(3):e0174221.
PMID: 28328987
PMC: 5362222.
DOI: 10.1371/journal.pone.0174221.
Geographic Population Structure in Epstein-Barr Virus Revealed by Comparative Genomics.
Chiara M, Manzari C, Lionetti C, Mechelli R, Anastasiadou E, Buscarinu M
Genome Biol Evol. 2016; 8(11):3284-3291.
PMID: 27635051
PMC: 5203774.
DOI: 10.1093/gbe/evw226.
Distribution, persistence and interchange of Epstein-Barr virus strains among PBMC, plasma and saliva of primary infection subjects.
Kwok H, Chan K, Chan K, Chiang A
PLoS One. 2015; 10(3):e0120710.
PMID: 25807555
PMC: 4373854.
DOI: 10.1371/journal.pone.0120710.
Epstein-Barr virus genetic variants are associated with multiple sclerosis.
Mechelli R, Manzari C, Policano C, Annese A, Picardi E, Umeton R
Neurology. 2015; 84(13):1362-8.
PMID: 25740864
PMC: 4388746.
DOI: 10.1212/WNL.0000000000001420.
Epstein-barr virus sequence variation-biology and disease.
Tzellos S, Farrell P
Pathogens. 2014; 1(2):156-74.
PMID: 25436768
PMC: 4235690.
DOI: 10.3390/pathogens1020156.
Epstein-Barr virus and nasopharyngeal carcinoma.
Young L, Dawson C
Chin J Cancer. 2014; 33(12):581-90.
PMID: 25418193
PMC: 4308653.
DOI: 10.5732/cjc.014.10197.
Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project.
Santpere G, Darre F, Blanco S, Alcami A, Villoslada P, Alba M
Genome Biol Evol. 2014; 6(4):846-60.
PMID: 24682154
PMC: 4104767.
DOI: 10.1093/gbe/evu054.
Epstein-Barr virus latent membrane protein 1 genetic variability in peripheral blood B cells and oropharyngeal fluids.
Renzette N, Somasundaran M, Brewster F, Coderre J, Weiss E, McManus M
J Virol. 2014; 88(7):3744-55.
PMID: 24429365
PMC: 3993555.
DOI: 10.1128/JVI.03378-13.
Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains.
Tierney R, Kao K, Nagra J, Rickinson A
J Virol. 2011; 85(23):12362-75.
PMID: 21957300
PMC: 3209410.
DOI: 10.1128/JVI.06059-11.
Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humans.
Orlova N, Wang F, Fogg M
J Virol. 2011; 85(23):12821-4.
PMID: 21917961
PMC: 3209403.
DOI: 10.1128/JVI.05742-11.
EBNA1 and LMP1 variants in multiple sclerosis cases and controls.
Simon K, Yang X, Munger K, Ascherio A
Acta Neurol Scand. 2010; 124(1):53-8.
PMID: 20636447
PMC: 2965795.
DOI: 10.1111/j.1600-0404.2010.01410.x.
Long-term administration of valacyclovir reduces the number of Epstein-Barr virus (EBV)-infected B cells but not the number of EBV DNA copies per B cell in healthy volunteers.
Hoshino Y, Katano H, Zou P, Hohman P, Marques A, Tyring S
J Virol. 2009; 83(22):11857-61.
PMID: 19740997
PMC: 2772668.
DOI: 10.1128/JVI.01005-09.
The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.
Chang C, Yu K, Mbulaiteye S, Hildesheim A, Bhatia K
Virus Res. 2009; 143(2):209-21.
PMID: 19596032
PMC: 2731007.
DOI: 10.1016/j.virusres.2009.07.005.
Laboratory assays for Epstein-Barr virus-related disease.
Gulley M, Tang W
J Mol Diagn. 2008; 10(4):279-92.
PMID: 18556771
PMC: 2438195.
DOI: 10.2353/jmoldx.2008.080023.
Role for HLA in susceptibility to infectious mononucleosis.
Farrell P
J Clin Invest. 2007; 117(10):2756-8.
PMID: 17909622
PMC: 1994638.
DOI: 10.1172/JCI33563.
Validation of Roche LightCycler Epstein-Barr virus quantification reagents in a clinical laboratory setting.
Gulley M, Fan H, Elmore S
J Mol Diagn. 2006; 8(5):589-97.
PMID: 17065428
PMC: 1876171.
DOI: 10.2353/jmoldx.2006.050152.